
Industrials · NSE / BSE
Founded in 2001 by Mr. Dhirajlal Kotadia, Sahajanand Medical Technologies Ltd. is a medical device company that focuses on advanced Class III and Class C/D devices used mainly in vascular and structural heart treatments. The company was the first in the world to receive CE certification for a drug-eluting stent with a biodegradable polymer called Infinnium. Its product range includes coronary stents and balloons for vascular interventions, technologies like TAVI and occluders for structural heart treatments, as well as renal stents and drug-coated balloons. The company operates R&D centres in India and Thailand and has a strong innovation base with over 100 granted patents and several pending applications. Its key products, including Supraflex Cruz, Hydra, and Cocoon, are supported by multiple clinical studies and are used in more than 76 countries. Sahajanand follows a global distribution strategy combining direct sales, hybrid models, and distributor partnerships across different markets. As of March 31, 2025, the company had over 1,400 employees along with consultants and contract staff supporting its operations.
Price Band
₹94 – ₹99
Issue Size
₹1768.30 L Cr
Lot Size
151 shares
GMP
-7.1%
Est. Listing
₹92
at current GMP
Subscribed
2.93x
overall
Open
25 Aug 2026
Close
28 Aug 2026
Allotment
31 Aug 2026
Refund
1 Sep 2026
Demat Credit
2 Sep 2026
Listing
2 Sep 2026
Designated Registrar: Kfin Technologies Limited
Allotment Date
31 Aug 2026
Basis finalization
Refunds Initiate
1 Sep 2026
Mandate release
Demat Credit
2 Sep 2026
Shares in demat
Listing Debut
2 Sep 2026
Trading begins
Annu Projects Limited is bringing an initial public offering (IPO) in the Industrials sector with an aggregate issue size of ₹1,76,83,000 Crores. The shares are offered at a price band of ₹94 to ₹99 per equity share on NSE and BSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2026-08-28, the basis of allotment is scheduled to be finalized on 2026-08-31. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Kfin Technologies Limited) or the BSE allotment checking window.
Allotment records are updated in batches. If the status is not yet available, please wait a few hours until the basis of allotment is fully finalized.
Since funds are blocked under ASBA/UPI, the bank will automatically release the blocked hold on your funds upon receipt of revocation instructions from the sponsor bank.